REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ever Supreme Bio Technology Co., Ltd. (Taiwan, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Ever Supreme Bio Technology Co., Ltd. Profile Updated: May 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Ever Supreme Bio Technology Co., Ltd. develops new drugs for stem cells, cancer immune cells, and provides innovative medical services. The company was founded in 2016 and is headquartered in Taichung City, Taiwan.

Headquarters
4F., No.30, Keya Rd., Daya Dist
Taichung City; Taichung City;

Contact Details: Purchase the Ever Supreme Bio Technology Co., Ltd. report to view the information.

Website: http://www.ever-superme.com.tw

Basic Information
Total Employees:
Purchase the Ever Supreme Bio Technology Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Ever Supreme Bio Technology Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Ever Supreme Bio Technology Co., Ltd. report to view the information.
Incorporation Date:
December 06, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
14.57%
Purchase this report to view the information.
12.41%
Purchase this report to view the information.
1.49%
Purchase this report to view the information.
1.14%
Purchase this report to view the information.
0.76%
Subsidiaries
聖陽生醫國際股份有限公司
100%
Company Performance
Financial values in the chart are available after Ever Supreme Bio Technology Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
23.57%▲
Total operating revenue
18.56%▲
Operating profit (EBIT)
88.5%▲
EBITDA
-15.35%▼
Net Profit (Loss) for the Period
-17.24%▼
Total assets
-10.39%▼
Total equity
-15.64%▼
Operating Profit Margin (ROS)
16.37%▲
Net Profit Margin
-19.87%▼
Return on Equity (ROE)
-0.17%▼
Quick Ratio
-4.4%▼
Cash Ratio
-3.96%▼

Similar companies

Feng Chi Biotech Corp.
 
Energenesis Biomedical CO.,Ltd.
Great Novel Therapeutics Biotech & Medic
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo